Dividend income
3 $
Earnings per share
14.85 $
Price/earnings (P/E)
19.1 $
Capitalization
151.69 billion $
Sector
Healthcare
Shares outstanding
534.9 million
Capitalization
151.69 billion $
Price/earnings (P/E)
19.1 $
Earnings per share
14.85 $
Dividend rate
8.52 $
Dividend income
3 $
Amgen Inc. - is an independent biotechnology pharmaceutical company that discovers, develops, manufactures and sells drugs for serious diseases. The company is engaged in the research, development, production and supply of various medicines for humans. The company operates in the segment of human medicines. The company specializes in the development of drugs for the treatment of severe oncological/hematological, cardiovascular and neurological diseases. was founded in 1980 and is a corporation organized under the laws of the State of Delaware.